Comparison of clinical and pathological tumour staging following CDK4/6 inhibitor-based neoadjuvant therapy in HR+/HER2− breast cancer
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Advanced Breast Cancer Therapies
Breast Cancer Treatment Studies
Breast Lesions and Carcinomas
Publication details
- Journal / source
- European Journal of Cancer
- Volume
- 237
- Pages
- 116505–116505
- Publication date
- 1 March 2026
- Language
- EN